Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/17 → 1/31/20 |
Funding
- Strategic Pharma-Academic Research Consortium (SPARC-17-06-A)
SPARC-17-06-A: Collaborative Study to Evaluate the Role of Neutrophil FCγ Receptor I (CD64 Index as a New Biomarker for Mucoasl Healing (MH) and Histologic Remission (HR) in Inflammatory Bowel Disease (IBD) Patients
Project: Research project